1
Clinical Trials associated with Gene-modified (GM) T cell therapy(Celgene)Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study.
Participants who received at least one infusion of GM T cells will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
100 Clinical Results associated with Gene-modified (GM) T cell therapy(Celgene)
100 Translational Medicine associated with Gene-modified (GM) T cell therapy(Celgene)
100 Patents (Medical) associated with Gene-modified (GM) T cell therapy(Celgene)
100 Deals associated with Gene-modified (GM) T cell therapy(Celgene)